Objectives

After participating in this educational activity, attendees should be able to:

1|Recognize best practices for inpatient handling, medication reconciliation, and mitigation of U-500 insulin dosing errors
2|Identify clinical scenarios in which U-500 insulin is appropriate for management of severe insulin resistance in type 2 diabetes
3|Differentiate concentrated regular U-500 insulin from U-100 insulin regarding pharmacokinetics, device options, and safety considerations
4|Apply evidence-based strategies to convert and titrate U-100 regimens to U-500 insulin using BID or TID dosing methods

 

Presenter(s): 
Brittney Brzoska, PharmD
PGY2 Ambulatory Care Pharmacy Resident
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Brittney Brzoska, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
11/17/2025 - 2:00pm to 3:00pm EST
Add to calendar: 
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours
Please login or register to take this course.